Faruqi & Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of MEDTOX
Scientific, Inc. (“MEDTOX” or the “Company”) (NASDAQ: MTOX) for
potential breaches of fiduciary duties in connection with their conduct
related to the sale of the Company to Laboratory Corporation of America®
Holdings (NYSE: LH) in an all-cash deal valued at about $241 million.
Under the terms of the proposed transaction, MEDTOX stockholders will
receive $27.00 in cash for each share of MEDTOX common stock they own.
Request more information now by clicking here: www.faruqilaw.com/MTOX.
There is no cost or obligation to you.
Whether the Board of Directors of MEDTOX breached their fiduciary duties
to the Company’s stockholders by failing to conduct an adequate and fair
sales process prior to agreeing to this proposed transaction, whether
the proposed transaction undervalues MEDTOX shares and by how much this
proposed transaction undervalues the Company to the detriment of MEDTOX
shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, throughout
all phases of litigation. The firm has an experienced trial team which
has achieved significant victories on behalf of the firm’s clients.
If you own common stock in MEDTOX and wish to obtain additional
information and protect your investments free of charge, please visit us
at www.faruqilaw.com/MTOX
or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.
